Filter
Period
Filter by
recent search
Showing: 1 – 05 of 152 Regulated Information
–
06 September 2022
06 September 2022
LinkedIn
Facebook
Share buyback program – Ipsen reporting from 29 August to 02 September 2022 – Detailled
This article or press release has no online content. Please download the associated documents for more information.
–
30 August 2022
30 August 2022
LinkedIn
Share buyback program – Ipsen reporting from 22 to 26 August 2022 – Detailled
This article or press release has no online content. Please download the associated documents for more information.
–
23 August 2022
23 August 2022
LinkedIn
Share buyback program – Ipsen reporting from 15 to 19 August 2022 – Detailed
This article or press release has no online content. Please download the associated documents for more information.
–
12 August 2022
12 August 2022
LinkedIn
Ipsen completes acquisition of Epizyme expanding its portfolio in oncology
PARIS, FRANCE, 12 August 2022 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced the closing of the definitive merger agreement under which Ipsen has acquired Epizyme, Inc. (Epizyme). Pursuant to the transaction, Ipsen acquires all outstanding shares of Epizyme for $1.45…
–
09 August 2022
09 August 2022
LinkedIn
Voting rights on 31 July 2022
This article or press release has no online content. Please download the associated documents for more information.